Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Men had worse COVID-19 outcomes than women in New York City.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Finasteride treats baldness but may cause lasting sexual side effects.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Male pattern baldness is not a risk factor for heart disease based on cholesterol levels alone.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.